Cargando…
Impact of receptor phenotype on nodal burden in patients with breast cancer who have undergone neoadjuvant chemotherapy
BACKGROUND: Optimal evaluation and management of the axilla following neoadjuvant chemotherapy (NAC) in patients with node‐positive breast cancer remains controversial. The aim of this study was to examine the impact of receptor phenotype in patients with nodal metastases who undergo NAC to see whet...
Autores principales: | Boland, M. R., McVeigh, T. P., O'Flaherty, N., Gullo, G., Keane, M., Quinn, C. M., McDermott, E. W., Lowery, A. J., Kerin, M. J., Prichard, R. S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5989970/ https://www.ncbi.nlm.nih.gov/pubmed/29951604 http://dx.doi.org/10.1002/bjs5.6 |
Ejemplares similares
-
Clinicopathological response to neoadjuvant therapies and pathological complete response as a biomarker of survival in human epidermal growth factor receptor-2 enriched breast cancer – A retrospective cohort study
por: Davey, Matthew G., et al.
Publicado: (2021) -
Investigating the association of rs2910164 with cancer predisposition in an Irish cohort
por: McVeigh, T P, et al.
Publicado: (2017) -
Prospective Assessment of Systemic MicroRNAs as Markers of Response to Neoadjuvant Chemotherapy in Breast Cancer
por: McGuire, Andrew, et al.
Publicado: (2020) -
Clinical use of the Oncotype DX genomic test to guide treatment decisions for patients with invasive breast cancer
por: McVeigh, Terri P, et al.
Publicado: (2017) -
Incidental Phaeochromocytoma on Staging PET-CT in a Patient with a Sigmoid Tumour and Situs Inversalis Totalis
por: Boland, M. R., et al.
Publicado: (2014)